Related Experiment Videos
Rotavirus vaccines: an update
1Division of Pediatric Infectious Diseases, Rhode Island Hospital and Brown Medical School, Providence, Rhode Island 02903, USA. pdennehy@lifespan.org
Current Opinion in Pediatrics
|January 22, 2005
Summary
Rotavirus vaccines are crucial for preventing severe diarrhea in children globally. New vaccine candidates offer hope for reducing rotavirus gastroenteritis, a major cause of infant mortality worldwide.
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- Rotavirus infection is a leading cause of severe diarrhea in infants and young children globally.
- It significantly impacts childhood morbidity and mortality worldwide.
- Vaccination is the primary strategy for controlling severe dehydrating rotavirus disease.
Purpose of the Study:
- To review the impact of rotavirus infection and the role of vaccination in disease prevention.
- To discuss the challenges and progress in developing new rotavirus vaccines.
Main Methods:
- Literature review of rotavirus infection and vaccine development.
- Analysis of global impact on childhood morbidity and mortality.
- Evaluation of current vaccine candidates in clinical trials.
Main Results:
- Rotavirus disease prevention faced a setback with the 1999 withdrawal of the RRV-TV vaccine.
- Several new rotavirus vaccine candidates have been developed.
- These candidates are currently undergoing clinical trials.
Conclusions:
- New, safe, and effective rotavirus vaccines are essential for reducing gastroenteritis.
- These vaccines represent the best hope for mitigating rotavirus disease burden in developed and developing nations.